SCHEMBL9827888

SCHEMBL9827888

CO/N=C(\C(=O)NC1C(=O)N2C(C(=O)OC(c3ccccc3)c3ccccc3)=C(CI)CS[C@H]12)c1csc(NC(c2ccccc2)(c2ccccc2)c2ccccc2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 2/20 0.53
▸ ABCB11 O95342 1/20 0.53
▸ PDE4D Q08499 1/20 0.53
▸ NR1I2 O75469 6/20 0.52
▸ HTR2C P28335 1/20 0.52
▸ MAPT P10636 3/20 0.51
▸ PPARG P37231 2/20 0.51
▸ SLC22A6 Q4U2R8 2/20 0.51
▸ SLC22A8 Q8TCC7 2/20 0.51
▸ SLC22A11 Q9NSA0 2/20 0.51
▸ ALB P02768 1/20 0.51
▸ KMT2A Q03164 1/20 0.49
▸ TDP1 Q9NUW8 4/20 0.48
▸ APEX1 P27695 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ ABCC4 O15439 1/20 0.48
▸ LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9361761 1.00 PTGS1 (0.53) PTGS1ABCB11PDE4DNR1I2HTR2C
SCHEMBL9827559 1.00 PTGS1 (0.53) PTGS1ABCB11PDE4DNR1I2HTR2C
SCHEMBL9623563 1.00 PTGS1 (0.53) PTGS1ABCB11PDE4DNR1I2HTR2C
SCHEMBL9623560 1.00 PTGS1 (0.53) PTGS1ABCB11PDE4DNR1I2HTR2C
SCHEMBL9361767 1.00 PTGS1 (0.53) PTGS1ABCB11PDE4DNR1I2HTR2C
SCHEMBL5712708 0.94 PTGS1 (0.52) PTGS1ABCB11PDE4DNR1I2HTR2C
SCHEMBL9200236 0.94 PTGS1 (0.52) PTGS1ABCB11PDE4DNR1I2HTR2C
SCHEMBL9361691 0.94 PTGS1 (0.52) PTGS1ABCB11PDE4DNR1I2HTR2C
SCHEMBL5712709 0.94 PTGS1 (0.52) PTGS1ABCB11PDE4DNR1I2HTR2C
SCHEMBL10635746 0.94 PTGS1 (0.52) PTGS1ABCB11PDE4DNR1I2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0182210-B1 CEPHALOSPORIN DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-02-27 — — EP disclosed
EP-0121244-B1 CEPHALOSPORIN DERIVATIVES Bristol-Myers Company (US) 1990-09-12 — — EP disclosed
US-4742053-A ANTIBIOTICS BANYU PHARMACEUTICAL CO., LTD. (JP) 1988-05-03 — — US disclosed
EP-0097961-B1 CEPHALOSPORIN DERIVATIVES, A PROCESS FOR THE MANUFACTURE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES Bristol-Myers Company (US) 1987-11-11 — — EP disclosed
EP-0182210-A2 Cephalosporin derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1986-05-28 — — EP disclosed
US-4525473-A BACTERICIDES BRISTOL-MYERS COMPANY (US) 1985-06-25 — — US disclosed
US-4507487-A CHEMICAL INTERMEDIATES FOR CEPHALOSPORINS BRISTOL-MYERS COMPANY (US) 1985-03-26 — — US disclosed
US-4500526-A ANTIBIOTICS, BACTERICIDES BRISTOL-MYERS COMPANY (US) 1985-02-19 — — US disclosed
US-4486586-A BACTERICIDAL ANTIBIOTICS BRISTOL-MYERS COMPANY (US) 1984-12-04 — — US disclosed
US-4457929-A BACTERICIDES BRISTOL-MYERS COMPANY (US) 1984-07-03 — — US disclosed
EP-0097961-A2 Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives Bristol-Myers Company (US) 1984-01-11 — — EP disclosed
Send feedback